-
Government & Regulation
Canada Mining Fiscal Landscape – Regulations Governance and Sustainability
Canada Mining Fiscal Landscape Report Overview Canada is one of the largest mineral producers globally and produces more than 60 metals and minerals, including potash, uranium, platinum, indium, and aluminium, among others. Furthermore, Canada is one of the world's largest bauxite importers. Canada’s mining industry is governed by different departments and agencies under provincial governments. However, in cases such as mineral activities on federal lands and offshore areas, as well as the usage of uranium as a nuclear fuel, a...
-
Analyst Opinions
NewUnited Kingdom (UK) Commercial Insurance Distribution Dynamics by Channels and Future Market, 2024 Update
United Kingdom (UK) Commercial Insurance Market Report Overview Brokers held more than 82% share of the UK commercial insurance market in 2023e, highlighting their dominance of the distribution landscape. The United Kingdom (UK) Commercial Insurance Distribution Dynamics by Channels and Future Market report each channel. The report also offers insights into the SME market and provides an outlook on the future of the distribution landscape, mentioning areas for brokers to develop, growth opportunities, and upcoming insurtech companies operating in the...
-
Sector Analysis
Pakistan Renewable Energy Policy Handbook, 2024 Update
Pakistan Renewable Energy Policy Report Overview The Pakistani government has taken up several initiatives in 2018-2019 to develop the renewable energy sector in the country. They increased their renewable energy target to attract more investors in the sector, revived several stalled renewable projects, and published the Alternative and Renewable Energy Policy (AREP) in 2019. There are various supporting schemes, such as FiT and net–metering in place to promote renewable energy sources in the country. The Pakistan Renewable Energy Policy Handbook...
-
Product Insights
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) - Drugs In Development, 2023’, provides an overview of the B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the...
-
Sector Analysis
Asia Pacific (APAC) Renewable Energy Policy Handbook, 2024 Update
Asia Pacific (APAC) Renewable Energy Policy Report Overview All Asia Pacific (APAC) countries covered in this report have set targets for renewable energy deployment and generation. A few countries have capacity targets, and a few have generation targets. In the APAC region, feed-in tariff (FiT) has been predominantly the most popular form of incentive utilized to promote renewable power installations. However, competitive bidding or auctions have also gained popularity in the APAC countries to promote renewable energy, especially solar PV,...
-
Sector Analysis
Vietnam Renewable Energy Policy Handbook, 2024 Update
Vietnam Renewable Energy Policy Overview The energy sector in the country is managed by the Ministry of Industry and Trade (MoIT), which is responsible for implementing some major reforms in the power sector to create a competitive market. A state-owned utility, Vietnam Electricity (EVN), is responsible for most of the generation, transmission, and distribution of power. Vietnamese government introduced various supporting schemes including FiTs, Avoided Cost Tariff (AVCT), and Corporate Income Tax (CIT) exemptions to promote the renewable energy sector...
-
Product Insights
B-Cell Chronic Lymphocytic Leukemia – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Drugs In Development, 2023’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Chronic Lymphocytic Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Gastrointestinal Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Gastrointestinal Tumor - Drugs In Development, 2023’, provides an overview of the Gastrointestinal Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Gastrointestinal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Drugs In Development, 2023
Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Drugs In Development, 2023’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...
-
Product Insights
B-Cell Leukemia – Drugs In Development, 2023
Global Markets Direct’s, ‘B-Cell Leukemia - Drugs In Development, 2023’, provides an overview of the B-Cell Leukemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for B-Cell Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...